Addus HomeCare (NASDAQ:ADUS) Receives New Coverage from Analysts at Macquarie

Macquarie started coverage on shares of Addus HomeCare (NASDAQ:ADUSFree Report) in a research report released on Friday, MarketBeat.com reports. The firm issued an outperform rating and a $136.00 price target on the stock.

A number of other research firms have also recently commented on ADUS. Bank of America raised their price target on shares of Addus HomeCare from $115.00 to $118.00 and gave the stock a buy rating in a report on Tuesday, May 7th. Oppenheimer raised their price target on shares of Addus HomeCare from $118.00 to $130.00 and gave the stock an outperform rating in a report on Friday, June 7th. Royal Bank of Canada restated an outperform rating and issued a $102.00 price target on shares of Addus HomeCare in a report on Thursday, February 29th. TD Cowen raised their price target on shares of Addus HomeCare from $119.00 to $128.00 and gave the stock a buy rating in a report on Tuesday, June 18th. Finally, StockNews.com cut shares of Addus HomeCare from a strong-buy rating to a buy rating in a report on Friday, June 21st. One equities research analyst has rated the stock with a sell rating, eight have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of Moderate Buy and an average target price of $116.25.

Get Our Latest Analysis on ADUS

Addus HomeCare Trading Up 0.0 %

ADUS opened at $116.16 on Friday. Addus HomeCare has a twelve month low of $78.35 and a twelve month high of $120.53. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.14. The company has a fifty day moving average of $110.16 and a 200-day moving average of $100.11. The stock has a market cap of $1.90 billion, a PE ratio of 28.82, a price-to-earnings-growth ratio of 1.77 and a beta of 1.01.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last posted its quarterly earnings data on Monday, May 6th. The company reported $1.21 earnings per share for the quarter, topping the consensus estimate of $0.97 by $0.24. Addus HomeCare had a net margin of 6.04% and a return on equity of 10.03%. The company had revenue of $280.70 million during the quarter, compared to analysts’ expectations of $279.49 million. During the same period in the prior year, the company posted $0.84 earnings per share. Addus HomeCare’s revenue for the quarter was up 11.6% compared to the same quarter last year. On average, sell-side analysts predict that Addus HomeCare will post 4.36 EPS for the current year.

Insider Buying and Selling at Addus HomeCare

In related news, EVP Roberton James Stevenson sold 217 shares of the firm’s stock in a transaction dated Monday, June 17th. The shares were sold at an average price of $116.13, for a total transaction of $25,200.21. Following the transaction, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at $1,186,500.21. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 4.60% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in ADUS. Boston Partners bought a new position in shares of Addus HomeCare during the first quarter valued at about $12,215,000. TimesSquare Capital Management LLC raised its position in Addus HomeCare by 55.0% in the third quarter. TimesSquare Capital Management LLC now owns 233,758 shares of the company’s stock worth $19,914,000 after acquiring an additional 82,920 shares during the period. Lord Abbett & CO. LLC bought a new stake in Addus HomeCare in the first quarter worth about $8,274,000. Allianz Asset Management GmbH bought a new stake in Addus HomeCare in the fourth quarter worth about $5,667,000. Finally, Vanguard Group Inc. raised its position in Addus HomeCare by 4.9% in the third quarter. Vanguard Group Inc. now owns 1,218,564 shares of the company’s stock worth $103,809,000 after acquiring an additional 57,040 shares during the period. 95.35% of the stock is owned by institutional investors.

About Addus HomeCare

(Get Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Further Reading

Analyst Recommendations for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.